The announcement arrives just two days after Halozyme reshuffled its executive suite, promoting interim Chief Financial Officer David Ramsay to the newly created role of president of drug delivery. Caudill’s exit leaves a significant vacancy in the company's operational hierarchy, with the firm maintaining silence regarding the timing of her replacement.
Halozyme COO Cortney Caudill Departs Company
Cortney Caudill is stepping down as chief operating officer of Halozyme Therapeutics, marking a sudden leadership shift for the biopharmaceutical firm. The company confirmed the executive’s exit in a Thursday filing with the Securities and Exchange Commission, though officials declined to offer a reason for her departure or name a successor.
Comments (0)
No comments yet. Be the first!